Secondary malignancies in <scp>non‐Hodgkin</scp> lymphoma survivors: 40 years of follow‐up assessed by treatment modality

Abstract

This is the largest study to examine SM risk in NHL patients with the longest follow-up. Treatment with radiotherapy did not increase overall SM risk, while chemotherapy was associated with a higher overall risk. However, certain subsites were associated with a higher risk of SM, and they varied by treatment, age group, race and time since treatment. These findings are helpful for informing screening and long-term follow-up in NHL survivors.